Promising approaches to early diagnosis of chronic rheumatic heart disease

Cover Page

Cite item

Full Text

Abstract

Aim – to determine the prevalence of acute rheumatic fever (ARF) in children and chronic rheumatic heart disease (HRHD) in adults on the example of the Samara region and to propose measures for the early detection and prevention of valvular heart lesions.

Material and methods. The authors cite the material of their own research, indicating a significant prevalence of rheumatic etiology of valvular lesions that required surgical treatment in 2016–2020 in the Samara region. We retrospectively analyzed the prevalence of acute rheumatic fever and chronic rheumatic heart disease in out-patients of a large polyclinic of Samara city.

Results. The study demonstrates the low frequency of acute rheumatic fever in the Russian Federation along with the disproportionately high prevalence of chronic rheumatic heart disease.

Conclusion. It is advisable to supplement the procedure for preventive medical examinations of the underage, has being in force in the territory of the Russian Federation since 2017, by ultrasound examination of the heart for the timely diagnosis of chronic rheumatic heart disease and long-term treatment with benzathine penicillin. In this case, it is also possible to identify previously undiagnosed congenital heart defects and heart diseases that manifest in adolescence.

About the authors

Galina V. Santalova

Samara State Medical University

Email: g.v.santalova@samsmu.ru
ORCID iD: 0000-0002-6078-2361

PhD, Professor, Head of the Department of Faculty pediatrics

Russian Federation, Samara

Andrei A. Garanin

Samara State Medical University

Author for correspondence.
Email: a.a.garanin@samsmu.ru
ORCID iD: 0000-0001-6665-1533

PhD, Assistant of the Chair of Introduction to internal medicine

Russian Federation, Samara

Petr A. Lebedev

Samara State Medical University

Email: p.a.lebedev@samsmu.ru
ORCID iD: 0000-0003-3501-2354

PhD, Professor, Head of the Department of Therapy, Institute of Professional Education

Russian Federation, Samara

Maksim E. Kuzin

Samara State Medical University

Email: kkide@yandex.ru
ORCID iD: 0000-0003-4656-3995

resident of the Department of Faculty Pediatrics

Russian Federation, Samara

Olga V. Tereshina

Samara State Medical University

Email: o.v.tereshina@samsmu.ru
ORCID iD: 0000-0003-0382-3363

PhD, Associate professor, Department of Therapy, Institute of Professional Education

Russian Federation, Samara

References

  1. He VY, Condon JR, Ralph AP, et al. Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach. Circulation. 2016;134(3):222-32. doi: 10.1161/CIRCULATIONAHA.115.020966
  2. Peters F, Karthikeyan G, Abrams J, et al. Rheumatic heart disease: current status of diagnosis and therapy. Cardiovasc Diagn Ther. 2020;10(2):305-315. doi: 10.21037/cdt.2019.10.07
  3. Watkins DA, Johnson CO, Colquhoun SM, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med. 2017;377(8):713-722. doi: 10.1056/NEJMoa1603693
  4. Sliwa K, White A, Milan P, et al. Momentum builds for a global response to rheumatic heart disease. Eur Heart J. 2018;39(48):4229-4232. doi: 10.1093/eurheartj/ehy763
  5. Watkins DA, Beaton AZ, Carapetis JR, et al. Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018;72(12):1397-1416. doi: 10.1016/j.jacc.2018.06.063
  6. Briko NI, Glushkova EV. The state and trends of the epidemic situation of streptococcal (group A) infection in Russia in recent years. Journal of Microbiology, Epidemiology and Immunobiology. 2018;1:10-6. (In Russ.). [Брико Н.И., Глушкова Е.В. Состояние и тенденции эпидемической ситуации по стрептококковой (группы А) инфекции в России в последние годы. Журнал микробиологии, эпидемиологии и иммунобиологии. 2018;1:10-6]. doi: 10.36233/0372-9311-2018-1-10-16
  7. Lamagni T, Guy R, Chand M, et al. Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. Lancet Infect Dis. 2018;18(2):180-187. doi: 10.1016/S1473-3099(17)30693-X
  8. Kuzmina NN, Medyntseva LG, Belov BS. Rheumatic fever: half a century of experience in studying the problem. Reflections of a rheumatologist. Rheumatology Science and Practice. 2017;55(2):125-137. (In Russ.). [Кузьмина Н.Н., Медынцева Л.Г., Белов Б.С. Ревматическая лихорадка: полувековой опыт изучения проблемы. Размышления ревматолога. Научно-практическая ревматология. 2017;55(2):125-137]. doi: 10.14412/1995-4484-2017-125-137
  9. Bonow RO, Carabello BA, Chatterjee K, et al. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation. 2008;118(15):e523-661. doi: 10.1161/CIRCULATIONAHA.108.190748
  10. Collection of statistical materials on diseases of the circulatory system, 2017. (In Russ.). [Сборник статистических материалов по болезням системы кровообращения, 2017].
  11. Roberts K, Colquhoun S, Steer A, et al. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013;10(1):49-58. doi: 10.1038/nrcardio.2012.157
  12. Mocumbi AO, Jamal KK, Mbakwem A, et al. The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease. Cardiovasc J Afr. 2018;29(6):394-403. doi: 10.5830/CVJA-2018-044
  13. Yacoub M, Mayosi B, ElGuindy A, et al. Eliminating acute rheumatic fever and rheumatic heart disease. Lancet. 2017;390(10091):212-213. doi: 10.1016/S0140-6736(17)31608-2
  14. Gewitz MH, Baltimore RS, Tani LY, et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015;131(20):1806-18. doi: 10.1161/CIR.0000000000000205
  15. Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015;36(18):1115-22a. doi: 10.1093/eurheartj/ehu449
  16. Roberts K, Colquhoun S, Steer A, et al. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013;10(1):49-58. doi: 10.1038/nrcardio.2012.157
  17. Saxena A, Ramakrishnan S, Roy A, et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart. 2011;97(24):2018-22. doi: 10.1136/heartjnl-2011-300792
  18. Saxena A, Zühlke L, Wilson N. Echocardiographic Screening for Rheumatic Heart Disease: Issues for the Cardiology Community. Global Heart. 2013;8(3):197-202. doi: 10.1016/j.gheart.2013.08.004
  19. McCarter R, Mirabel M, Mirembe G, et al. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome. Circulation. 2017;136(23):2233-2244. doi: 10.1161/CIRCULATIONAHA.117.029936

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Santalova G.V., Garanin A.A., Lebedev P.A., Kuzin M.E., Tereshina O.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).